Pfizer on Friday committed to supply up to 40 million doses of its COVID-19 vaccine this year to a World Health Organization-backed effort to get affordable ...

Questions arising about the safety of the new Pfizer vaccine. Some elderly people are reportedly dying hours or days after taking the vaccine. The highly anticipated ...

Thousands of people have been unable to work or perform daily activities, or required care from a healthcare professional, after getting the new COVID-19 vaccine, according ...

NEW YORK—The U.S. Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE’s COVID-19 vaccine ...

Vice President Mike Pence will be injected with the newly approved COVID-19 vaccine in an event on Friday, while Joe Biden plans to get vaccinated soon.

Two health workers in Alaska suffered allergic reactions, one of which was serious, after receiving the COVID-19 vaccine made by Pfizer and BioNTech.

The Food and Drug Administration is finalizing its approval of the Pfizer-BioNTech COVID-19 vaccine

WASHINGTON—A 23-member vaccine advisory panel voted on Dec. 10 to support the emergency use authorization (EUA) of the COVID-19 vaccine created by Pfizer-BioNTech. The final decision ...

U.S. stocks are slipping Wednesday and pulling back from their recent record highs as virus cases surge and coronavirus vaccines move closer to distribution. A vaccine ...

The Pfizer/BioNTech vaccine is the first to be approved by the UK regulator and will be available for use in the UK within days, the government ...

In Phase 3 of clinical trials, Pfizer said it found that it’s vaccine, known as BNT162b2, was 95 percent effective in developing an immunity to COVID-19.

Pfizer has filed for emergency use authorization of its COVID-19 vaccine on Friday

One of the leading COVID-19 vaccine candidates was 94 percent effective in adults older than 65, according to new clinical trial results.

Pfizer Inc has launched a pilot delivery program for its experimental COVID-19 vaccine in four U.S. states, as the U.S. drugmaker seeks to address distribution challenges ...

On Monday, Pfizer and its German partner Bio-N-Tech announced that it had preliminary results for a vaccine that’s more than 90 percent effective. It sounds like ...

Pfizer's CEO sold shares worth $5.6 million the day the drugmaker announced that its CCP virus vaccine was more than 90 percent effective.

1. UK hospital: 600 staff off due to COVID-19 2. Germans skeptical about Pfizer’s COVID vaccine 3. Two Belarusian diplomats expelled from UK 4. Denmark mink ...

A COVID-19 vaccine candidate proved strongly effective in a large phase 3 study, according to results released on Nov. 9.

The US presidential election is having an impact on Chinese stocks. It spells both good and bad news for the communist regime.

Pfizer Inc received informal requests relating to its operations in China from the U.S. Department of Justice and the U.S. Securities and Exchange Commission

President Donald Trump is set to deliver remarks and sign a series of executive orders on lowering drug prices at 3.00 pm EDT (1900 GMT) on Friday, ...

WASHINGTON—The Trump administration will pay Pfizer nearly $2 billion for a December delivery of 100 million doses of a COVID-19 vaccine the pharmaceutical company is developing, ...

Pfizer to Buy Array BioPharma in Deal Worth $11.4 Billion